<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03542240</url>
  </required_header>
  <id_info>
    <org_study_id>HM20012060</org_study_id>
    <nct_id>NCT03542240</nct_id>
  </id_info>
  <brief_title>Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome</brief_title>
  <official_title>Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effects of curcumin on the structure/function of the body by&#xD;
      investigating whether targeted improvement of intestinal barrier function by supplementation&#xD;
      with oral curcumin will result in attenuation of lipopolysaccharide (LPS) translocation&#xD;
      and/or intestinal inflammation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A typical diet in the United States, also known as Western diet, is very high in sugars and&#xD;
      saturated fat, and poor in food such as fruits, vegetables, fish and whole grains. This type&#xD;
      of diet is associated with higher risk to develop obesity and other health problems such as&#xD;
      high blood pressure, high cholesterol, Type 2 diabetes, and heart disease. Western diet can&#xD;
      also cause changes in the gut that allow bacteria that are typically only present in the gut&#xD;
      to leak out into the bloodstream. It is thought that having gut bacteria in the bloodstream&#xD;
      may play a role in the development of diseases like Type 2 diabetes and heart disease.&#xD;
&#xD;
      Curcumin is a dietary supplement that comes from the root of the turmeric plant, and it may&#xD;
      have an effect on the function of the gut and the leakage of gut bacteria into the&#xD;
      bloodstream. The purpose of this research study is to evaluate the effects of daily curcumin&#xD;
      dietary supplements on the function of the gut in subjects who are at risk for cardiovascular&#xD;
      and metabolic diseases, for example they have increased blood pressure, increase waist&#xD;
      circumference and high triglycerides (fat in the blood).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 19, 2018</start_date>
  <completion_date type="Actual">November 13, 2020</completion_date>
  <primary_completion_date type="Actual">November 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change inintestinal permeability</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Measured by level plasma lipopolysaccharide (LPS). A reduction in LPS suggests a reduction in intestinal permeability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in intestinal barrier function</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Measured by level of excreted Zonulin in stool samples. A reduction in Zonulin suggests a reduction in intestinal barrier function</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Obesity</condition>
  <condition>High Blood Pressure</condition>
  <condition>High Cholesterol</condition>
  <condition>Type2 Diabetes</condition>
  <condition>Heart Diseases</condition>
  <arm_group>
    <arm_group_label>Curcumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Curcumin</intervention_name>
    <description>500 milligram daily supplement</description>
    <arm_group_label>Curcumin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Based on National Institutes of Health (NIH) definition of Metabolic syndrome, the&#xD;
             subject must meet at least 3 of the following criteria:&#xD;
&#xD;
             A. Waist Circumference: Female ≥ 88 cm, Male ≥ 102 cm B. Blood Pressure: ≥ 130/85&#xD;
             mm/Hg and/or treatment with blood pressure lowering medication C. Impaired fasting&#xD;
             glucose or HbA1c (fasting glucose ≥ 100 mg/dl or HgA1c ≥ 5.7 D. HDL-C: Females&lt; 50&#xD;
             mg/dl, Males &lt; 40 mg/dl E. Triglycerides ≥ 150 mg/dl&#xD;
&#xD;
          2. Willing and able to comply with the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Diabetes&#xD;
&#xD;
          2. Established cardiovascular disease&#xD;
&#xD;
          3. Pre-existing liver disease other than NAFLD&#xD;
&#xD;
          4. Chronic kidney disease (Stage 4 and 5)&#xD;
&#xD;
          5. Rheumatological disease&#xD;
&#xD;
          6. Active malignancy&#xD;
&#xD;
          7. Alcohol consumption greater than 7 drinks per week for females and greater than 14&#xD;
             drinks per week for males&#xD;
&#xD;
          8. Current use of metformin and/or steroids&#xD;
&#xD;
          9. Curcumin supplementation&#xD;
&#xD;
         10. Females of child-bearing potential (NOT of child-bearing potential is defined as s/p&#xD;
             hysterectomy or post-menopausal.)&#xD;
&#xD;
         11. Prisoners/wards of the state and individuals with limited English proficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Wolver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>May 18, 2018</study_first_submitted>
  <study_first_submitted_qc>May 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>curcumin</keyword>
  <keyword>microbiome</keyword>
  <keyword>dietary supplements</keyword>
  <keyword>gut bacteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

